Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Neoplasms 15 Papillomavirus Infections 9 Uterine Cervical Neoplasms 7 Pancreatic Neoplasms 6 Breast Neoplasms 6 Ovarian Neoplasms 5 Prostatic Neoplasms 4 Neuroendocrine Tumors 4 Neoplasm Metastasis 4 Myasthenia Gravis 3 Multiple Myeloma 3 Melanoma 3 Lymphoma 3 Lung Neoplasms 3 Autoimmune Diseases 3 Thyroid Diseases 2 Pancreatic Cyst 2 Neuroblastoma 2 Mesothelioma, Malignant 2 Lymphoma, Non-Hodgkin 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia, Hairy Cell 2 Leukemia 2 Hematologic Neoplasms 2 Endometrial Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma, Non-Small-Cell Lung 2 COVID-19 2 Brain Neoplasms 2 Abortion, Spontaneous 2

Interventions

Brentuximab Vedotin 21 Cyclophosphamide 20 fludarabine 16 Rituximab 13 Lenalidomide 13 Dexamethasone 12 fludarabine phosphate 10 Melphalan 10 Busulfan 10 Mycophenolic Acid 9 pirtobrutinib 7 dacetuzumab 7 Whole-Body Irradiation 7 Tacrolimus 7 Bortezomib 7 Doxorubicin 6 Azacitidine 6 ruxolitinib 5 Vincristine 5 Prednisone 5 Imatinib Mesylate 5 Bone Marrow Transplantation 5 ponatinib 4 pomalidomide 4 Mesna 4 Granulocyte Colony-Stimulating Factor 4 Etoposide 4 Blood Specimen Collection 4 Bendamustine Hydrochloride 4 venetoclax 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Hematologic Diseases × Data Collection × Clear all

NCT03868527 2019-03-11

Arcan database

Hospices Civils de Lyon

13,000 enrolled

Hematologic Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡